Completed OBSERVATIONAL NCT03974464

Copeptin and the S-100b Protein in Stroke

Value of Copeptin and the S-100b Protein Assay in Ruling Out the Diagnosis of Stroke-induced Dizziness Pattern in Emergency Departments

Sponsor: Poitiers University Hospital

Conditions Vertigo, Brain Stem Vertigo, Peripheral Vertigo; Central Vertigo; Cerebral

Interventions copeptin, PS100

Updated 6 times since 2019 Last updated: Jun 3, 2019 Started: May 1, 2016 Primary completion: Jan 31, 2018 Completion: Jan 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Vertigo, Brain Stem and Vertigo, Peripheral, this trial is completed. The trial is conducted by Poitiers University Hospital and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 1 earlier version

Jul 2019 — Nov 2020 [monthly]

Completed

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Poitiers University Hospital

Data source: Poitiers University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.